Navigation Links
Novavax Reports Fourth Quarter and 2008 Year-End Financial Results
Date:3/31/2009

ifferentiated, value-added vaccines that leverage our proprietary VLP technology. These increases were primarily for increased personnel, facility costs and outside expenses (including sponsored research, clinical research organization costs and consulting agreements) associated with expanded preclinical studies, human trial study costs, process development, manufacturing and quality-assurance and quality-control related activities.

General and administrative costs were $3.4 million in the fourth quarter of 2008 as compared to $2.9 million in the prior year. General and administrative costs for the full year of 2008 were $11.1 million compared to $13.9 million in 2007. General and administrative expenses for the year ended December 31, 2008 decreased by $2.8 million primarily due to a $1.2 million credit recorded to the allowance established for two notes receivable from former directors. General and administrative expenses for the year ended December 31, 2008 were also impacted by lower facility costs and lower employee costs. These decreases were offset by an impairment charge related to the Company's MNP assets.

As a result, total losses from continuing operations before interest was $11.0 million and $36.3 million for the fourth quarter and full year of 2008, respectively.

Our interest and other expense was $1.4 million in the fourth quarter of 2008 and $2.0 million for the full year as compared to net interest income of $0.3 million in the fourth quarter of 2007 and $1.7 million for the full year of 2007. The decrease in net interest and other income in the fourth quarter 2008 when compared to the fourth quarter of 2007 resulted from an impairment of the Company's auction rate securities. There has been insufficient demand at auction for the Company's auction rate securities and, in December 2008, the Company recorded an other than temporary impairment charge of $1.2 million on these investments due pr
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
2. Novavax CEO to Present at the Partnering for Global Health Forum
3. Novavax CEO to Present at Susquehannas Second SIGnificant Options in Healthcare Conference
4. Novavax Announces Release Date of 2007 Third Quarter Financial Results and Investor Conference Call
5. Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb
6. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
7. Cadus Reports 2008 Results
8. Nephros Reports 2008 Fourth Quarter and Full Year Financial Results
9. Cardiogenesis Reports Fourth Quarter and Fiscal Year 2008 Results
10. Tiens Biotech Group (USA) Reports Record Twelve-Month Results
11. ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 06, 2015 Experienced Vancouver air conditioning ... announced that they will now conduct their cooling services, ... in addition to commercial and residential units. Strata complex ... a lot of technical knowledge as well as a ... installation we will take away any old air conditioning ...
(Date:5/6/2015)... Fla. (PRWEB) May 06, 2015 ... Institute are the first in north Florida and ... technology is the latest innovation in total hip ... highly advanced, surgeon-controlled robotic arm that enables the ... Medical Center Jacksonville has offered MAKOplasty® partial knee ...
(Date:5/6/2015)... Is Colorado’s legal cannabis industry the victim ... State will mark the 18-month milestone of its historic ... while Colorado’s legal marijuana industry has been successful and ... facing some new challenges. , For example, many marijuana ... in the wake of last month’s “420” cannabis celebrations. ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Vancouver ... recently shared their new blog containing the Canadian ... by the Canadian Society for Exercise Physiology (CSEP). ... physical activity, health and fitness research and personal ... and exercise are highly beneficial and a rich ...
(Date:5/6/2015)... In March, Dr. Rami K. Batniji ... Masterclass. As Europe’s most exclusive rhinoplasty conference, the attendees ... Dr. Batniji was hand chosen to speak by the President ... Dr. Pietro Palma. , The Milano Masterclass is ... hosts a diverse, multi-national faculty; each considered a rhinoplasty expert ...
Breaking Medicine News(10 mins):Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:California Surgeon Speaks at International Rhinoplasty Conference 2
... Learning, Arts, and the Brain, a study three years ... cognitive neuroscientists from seven leading universities in the United ... at a news conference at the Dana Foundations Washington, ... smart people drawn to the arts or does arts ...
... unveil report at Tuesday event attended by local health ... care,industry senior executive is 51 years old, the sole ... with revenue of more than $250M per year.,Did we ... that she is,rarely given the chance to participate on ...
... Md., March 4 Dozens of AARP,members ... in Annapolis today as,the General Assembly considered ... protections against identity theft, and the creation ... legislators,offices and attended committee hearings on legislation ...
... backs three non-profit organizations, SEATTLE, March 4 ... it is backing three,important non-profit organizations, in an effort ... Important, Aside from non-melanoma skin cancer, breast cancer ... cancer is the number one cause of cancer,death in ...
... lasting knee, MEMPHIS, Tenn. and SAN ... (NYSE: SNN , LSE: SN) Orthopaedic ... VERILAST(TM) Technology.,VERILAST Technology represents a technological leap ... VERILAST Technology is an,optimized material combination engineered ...
... Parents and Caregivers to Take Action Against This Leading ... Cause of Home-Related ... Safety Council, accidental poisoning is the second leading,cause of home injury ... found that only one percent of U.S. adults ranked poisoning at ...
Cached Medicine News:Health News:Dana Foundation releases arts and cognition research 2Health News:New WBL Foundation Survey Shows Robust Pool of Women Available for Corporate Board Service 2Health News:New WBL Foundation Survey Shows Robust Pool of Women Available for Corporate Board Service 3Health News:Utilities, Long Term Care Bills at Center of 'AARP Day In Annapolis' 2Health News:Leading Natural Cosmetics Company Supports Breast Cancer Survivors 2Health News:Leading Natural Cosmetics Company Supports Breast Cancer Survivors 3Health News:Leading Natural Cosmetics Company Supports Breast Cancer Survivors 4Health News:Smith & Nephew Announces Breakthrough VERILAST(TM) Technology 2Health News:Smith & Nephew Announces Breakthrough VERILAST(TM) Technology 3Health News:Smith & Nephew Announces Breakthrough VERILAST(TM) Technology 4Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 2Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 3Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 4
(Date:5/6/2015)... SEATTLE , May 6, 2015  LumiThera Inc., ... non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, ... agreed to join LumiThera,s Advisory Board to assist in ... Norman DeValois "Norm" Dicks was the U.S. Representative ... serving between 1977 and 2013. He is a member ...
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... "Energy based Ablation Devices - Global Strategic Business Report" ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of World. ... through 2020. Also, a seven-year historic analysis is provided for ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4fgrnh/asiapacific ) ... Internal Trauma Fixation Devices Market by Type & ... report to their offering. The ... to grow at a CAGR of 6.7% from ... rising incidences of road accidents, increasing aging population, ...
Breaking Medicine Technology:Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2
... 2011 MedTrust Online (MedTrust) and Avantra Biosciences ... clinicians in the earliest stages of molecular diagnostic ... immunoassay system. The two companies ... cancer care professionals with early access to the ...
... 2011 Highlights: ... oncology therapy to India Innovative provider-technology alliance will enable ... IT growth initiative Harris Corporation (NYSE: ... International (CTSI), a leading developer, owner, and operator of outpatient ...
Cached Medicine Technology:Avantra Biosciences and MedTrust Online Partner to Develop Clinically Important Protein Biomarker Assays for Improving Cancer Care 2Avantra Biosciences and MedTrust Online Partner to Develop Clinically Important Protein Biomarker Assays for Improving Cancer Care 3Harris Corporation and Cancer Treatment Services International Team to Enhance Cancer Treatment and Availability 2
Anterior Stromal Puncture Cannula, 25 g. For treatment of recurrent corneal erosion. Overall length 24 mm. 5/box....
Lacrimal Cannulas, 19 g. shaft tapering to 23 g. curved cannula. Overall length 37.7 mm. 5/box....
Viscoelastic Cannula, 27 g. Angled. 7 mm angled tip cannula with unique hub that facilitates flow of viscoelastic material. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 21 g., 8 mm from bend to tip. Overall length 25 mm. 5/box....
Medicine Products: